Prestige Diagnostics UK Ltd 31/07/2025 iXBRL

Company registration number: NI610548

Prestige Diagnostics UK Ltd

Unaudited filleted financial statements

31 July 2025

Prestige Diagnostics UK Ltd

Contents

Directors and other information

Accountants report

Balance sheet

Notes to the financial statements

Prestige Diagnostics UK Ltd

Directors and other information


	Directors	Mr Alan Rodgers
		Mrs Brigie Rodgers


	Company number	NI610548


	Registered office	65 Fenaghy Road
		Galgorm
		Ballymena
		Co Antrim
		BT42 1HW


	Business address	65 Fenaghy Road
		Galgorm
		Ballymena
		Co Antrim
		BT42 1HW


	Accountants	Potter Finnegan Limited
		27-28 The Courtyard Business Park
		190 Galgorm Road
		Ballymena
		Co Antrim
		BT42 1HL




	Bankers	Bank of Ireland
		5th Floor
		1 Donegall Square South
		Belfast
		BT1 5LR

Prestige Diagnostics UK Ltd

Report to the board of directors on the preparation of the

unaudited statutory financial statements of Prestige Diagnostics UK Ltd

Year ended 31 July 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Prestige Diagnostics UK Ltd for the year ended 31 July 2025 which comprise the Balance sheet and related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of Chartered Accountants Ireland , we are subject to its ethical and other professional requirements which are detailed at www.charteredaccountants.ie.

This report is made solely to the board of directors of Prestige Diagnostics UK Ltd, as a body, in accordance with the terms of our engagement letter dated 13 November 2024. Our work has been undertaken solely to prepare for your approval the financial statements of Prestige Diagnostics UK Ltd and state those matters that we have agreed to state to the board of directors of Prestige Diagnostics UK Ltd as a body, in this report in accordance with the requirements of Chartered Accountants Ireland as detailed at www.charteredaccountants.ie. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Prestige Diagnostics UK Ltd and its board of directors as a body for our work or for this report.

It is your duty to ensure that Prestige Diagnostics UK Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Prestige Diagnostics UK Ltd. You consider that Prestige Diagnostics UK Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Prestige Diagnostics UK Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Potter Finnegan Limited

Chartered Accountants

27-28 The Courtyard Business Park

190 Galgorm Road

Ballymena

Co Antrim

BT42 1HL

15 December 2025

Prestige Diagnostics UK Ltd

Balance sheet

31 July 2025

		2025		2024
	Note	£	£	£	£

Fixed assets
Tangible assets	4	118,770		793,939
Investments	5	-		682,486
		_______		_______
			118,770		1,476,425

Current assets
Stocks	6	22,000		34,244
Debtors	7	1,539,373		667,542
Cash at bank and in hand		567		11,814
		_______		_______
		1,561,940		713,600
Creditors: amounts falling due
within one year	8	( 186,372)		( 444,430)
		_______		_______
Net current assets			1,375,568		269,170
			_______		_______
Total assets less current liabilities			1,494,338		1,745,595


Provisions for liabilities	9		( 29,693)		( 102,693)

			_______		_______
Net assets			1,464,645		1,642,902
			_______		_______

Capital and reserves
Called up share capital	11		10		10
Profit and loss account			1,464,635		1,642,892
			_______		_______
Shareholders funds			1,464,645		1,642,902
			_______		_______

For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the Profit and loss account has not been delivered.

These financial statements were approved by the board of directors and authorised for issue on 15 December 2025 , and are signed on behalf of the board by:

Mr Alan Rodgers Mrs Brigie Rodgers

Director Director

Company registration number: NI610548

Prestige Diagnostics UK Ltd

Notes to the financial statements

Year ended 31 July 2025

1. General information

The company is a private company limited by shares, registered in Northern Ireland. The address of the registered office is Prestige Diagostics UK Ltd, 65 Fenaghy Road, Galgorm, Ballymena, Co Antrim, BT42 1HW.

2. Statement of compliance

These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Tangible assets

tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.

Fixed asset investments

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the Balance sheet and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.

4. Tangible assets

	Freehold property	Plant and machinery	Fixtures, fittings and equipment	Total
	£	£	£	£
Cost
At 1 August 2024	397,656	208,747	417,175	1,023,578
Disposals	( 397,656)	( 24,921)	( 390,957)	( 813,534)
	_______	_______	_______	_______
At 31 July 2025	-	183,826	26,218	210,044
	_______	_______	_______	_______
Depreciation
At 1 August 2024	14,725	54,321	160,593	229,639
Charge for the year	-	18,383	403	18,786
Disposals	( 14,725)	( 4,822)	( 137,604)	( 157,151)
	_______	_______	_______	_______
At 31 July 2025	-	67,882	23,392	91,274
	_______	_______	_______	_______
Carrying amount
At 31 July 2025	-	115,944	2,826	118,770
	_______	_______	_______	_______
At 31 July 2024	382,931	154,426	256,582	793,939
	_______	_______	_______	_______

5. Investments

	Other investments other than loans	Total
	£	£
Cost
At 1 August 2024	682,486	682,486
Disposals	( 682,486)	( 682,486)
	_______	_______
At 31 July 2025	-	-
	_______	_______
Impairment
At 1 August 2024 and 31 July 2025	-	-
	_______	_______
Carrying amount
At 31 July 2025	-	-
	_______	_______
At 31 July 2024	682,486	682,486
	_______	_______

6. Stocks

	2025	2024
	£	£
Finished goods and goods for resale	22,000	34,244
	_______	_______

7. Debtors

	2025	2024
	£	£
Trade debtors	7,054	84,969
Amounts owed by group undertakings and undertakings in which the company has a participating interest	1,521,888	504,916
Other debtors	10,431	77,657
	_______	_______
	1,539,373	667,542
	_______	_______

8. Creditors: amounts falling due within one year

	2025	2024
	£	£
Bank loans and overdrafts	57	132
Trade creditors	17,731	3,123
Amounts owed to group undertakings and undertakings in which the company has a participating interest	-	37,629
Corporation tax	147,831	305,476
Social security and other taxes	7,479	18,133
Other creditors	13,274	79,937
	_______	_______
	186,372	444,430
	_______	_______

9. Provisions

	Deferred tax (note 10)	Total
	£	£
At 1 August 2024	102,693	102,693
Charges against provisions	( 73,000)	( 73,000)
	_______	_______
At 31 July 2025	29,693	29,693
	_______	_______

10. Deferred tax

The deferred tax included in the Balance sheet is as follows:

	2025	2024
	£	£
Included in provisions (note 9)	29,693	102,693
	_______	_______

The deferred tax account consists of the tax effect of timing differences in respect of:

	2025	2024
	£	£
Accelerated capital allowances	29,693	102,693
	_______	_______

11. Called up share capital

Issued, called up and fully paid

	2025		2024
	No	£	No	£
Ordinary shares of £ 1.00 each	10	10	10	10
	_______	_______	_______	_______

12. Related party transactions

During the year the company entered into the following transactions with related parties:

	Transaction value		Balance owed by/(owed to)
	2025	2024	2025	2024
	£	£	£	£
Loan to group company	-	-	-	504,916
Loan to/(from) parent company	-	-	1,521,888	( 37,629)
	_______	_______	_______	_______

For several years the company has provided a loan to a group company. During the year this loan was transferred from the recipient company to the parent company. At 31 July 2024 the company had a loan from its parent company. At the year end the company provided a loan to its parent company. The loan is interest free and repayable on demand. This is included in debtors.

13. Controlling party

The company is controlled by the directors.